ArticleCell death & disease2023

Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.

Shiao-Ya Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.